Companies Cryptocurrencies
Sinovac Biotech Ltd
Sinovac Biotech Ltd
Exchange: Nasdaq Global Select
IPO Date: 13/11/2009
CEO: Mr. WeiDong Yin
Biotechnology Healthcare 🔗
  • SVA
  • price
  • market cap
  • changes
If you bought

shares of Sinovac Biotech Ltd (SVA) on
You would have made
Old Price $12 Current Price $12

Sinovac Biotech Ltd. is a holding company, which engages in the research, development, manufacture, and commercialization of vaccines that protect against human infectious diseases. The company is headquartered in Beijing, Beijing and currently employs 735 full-time employees. The firm is a biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases, including hepatitis A, hepatitis B, seasonal influenza, Haemagglutinase5 Neuraminidase1 (H5N1) and Influenza A (H1N1) pandemic influenza and mumps. The firm’s pipeline consists of vaccine candidates in the clinical and pre-clinical development Phases in China. The firm is engaged in the sales, marketing, manufacturing and development of vaccines for infectious disease. The firm develops various products, including Healive, Bilive, Anflu, Panflu Whole Viron Pandemic Influenza Vaccine, Split Viron Pandemic Influenza Vaccine, Panflu.1, RabEnd, Mumps Vaccine, Enterovirus 71 (EV71) Vaccine, Pneumococcal Polysaccharide Vaccine, Pneumococcal Conjugate Vaccine, Rubella Vaccine, Varicella Vaccine and Sabin Inactivated Polio Vaccine.

Address: 39 Shangdi Xi Road Haidian District Beijing BEIJING 100085

Stay updated.